Literature DB >> 639614

[Dilatation or sphincterotomy as the treatment of primary-chronic fissure in ano. Results of a random, clinical study after 2-3 years].

M Fischer, H Hamelmann.   

Abstract

In a randomized clinical trial, 66 patients were treated for primary chronic fissure-in-ano by anal dilatation or sphincterotomy. Of the 64 patients still living, 57 (89.0%) could be submitted to a follow-up examination 26.7 +/- 4.6 months after the operation; 63 of them were surveyed on the basis of a questionnaire. Six patients who had reported functional lesions after operation at a six-month follow-up were reexamined: in two cases improvements were recorded, in the case of three patients the symptoms remained unchanged, and in one case a complete reduction was achieved. Though no significant difference (p less than 0.1) was noted with a recurrence rate of 20.5% (n = 7) after the dilatation versus 3.1% (n = 1) after the sphincterotomy, a definite trend was obvious. These findings support the sphincterotomy as being a definitive therapy for primary chronic fissure-in-ano.

Entities:  

Mesh:

Year:  1978        PMID: 639614

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  4 in total

1.  [Randomized and nonrandomized controlled clinical trials in a German surgical journal].

Authors:  M K Diener; A Blümle; V Szakallas; G Antes; C M Seiler
Journal:  Chirurg       Date:  2006-09       Impact factor: 0.955

Review 2.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

Review 3.  [Prospective controlled clinical trials in surgery. controversial issues in motivation and performance (author's transl)].

Authors:  W Lorenz; H Rohde
Journal:  Klin Wochenschr       Date:  1979-04-01

Review 4.  Operative and medical treatment of chronic anal fissures-a review and network meta-analysis of randomized controlled trials.

Authors:  Sabrina Maria Ebinger; Julia Hardt; René Warschkow; Bruno Martin Schmied; Alexander Herold; Stefan Post; Lukas Marti
Journal:  J Gastroenterol       Date:  2017-04-10       Impact factor: 7.527

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.